NL190373C - Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat. - Google Patents

Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat.

Info

Publication number
NL190373C
NL190373C NLAANVRAGE8500202,A NL8500202A NL190373C NL 190373 C NL190373 C NL 190373C NL 8500202 A NL8500202 A NL 8500202A NL 190373 C NL190373 C NL 190373C
Authority
NL
Netherlands
Prior art keywords
preparation
carbazolone
dihydro
substituted aminomethyl
pharmaceutical preparation
Prior art date
Application number
NLAANVRAGE8500202,A
Other languages
English (en)
Other versions
NL190373B (nl
NL8500202A (nl
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848401888A external-priority patent/GB8401888D0/en
Priority claimed from GB848425959A external-priority patent/GB8425959D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8500202A publication Critical patent/NL8500202A/nl
Publication of NL190373B publication Critical patent/NL190373B/nl
Application granted granted Critical
Publication of NL190373C publication Critical patent/NL190373C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
NLAANVRAGE8500202,A 1984-01-25 1985-01-25 Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat. NL190373C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB848401888A GB8401888D0 (en) 1984-01-25 1984-01-25 Heterocyclic compounds
GB848425959A GB8425959D0 (en) 1984-10-15 1984-10-15 Heterocyclic compounds
GB8425959 1984-10-15
GB8401888 1985-01-25

Publications (3)

Publication Number Publication Date
NL8500202A NL8500202A (nl) 1985-08-16
NL190373B NL190373B (nl) 1993-09-01
NL190373C true NL190373C (nl) 1994-02-01

Family

ID=26287221

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE8500202,A NL190373C (nl) 1984-01-25 1985-01-25 Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat.
NL940009C NL940009I2 (nl) 1984-01-25 1994-05-31 Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1H)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutischpreparaat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL940009C NL940009I2 (nl) 1984-01-25 1994-05-31 Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1H)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutischpreparaat.

Country Status (29)

Country Link
KR (1) KR920003064B1 (nl)
AT (1) AT392276B (nl)
AU (1) AU579132B2 (nl)
BE (1) BE901576A (nl)
CA (1) CA1252793A (nl)
CH (1) CH664152A5 (nl)
CY (1) CY1479A (nl)
CZ (1) CZ404391A3 (nl)
DE (2) DE19375046I2 (nl)
DK (1) DK169521B1 (nl)
ES (3) ES8609309A1 (nl)
FI (1) FI84349C (nl)
FR (1) FR2561244B1 (nl)
GB (1) GB2153821B (nl)
GR (1) GR850219B (nl)
HK (1) HK33189A (nl)
HU (1) HU193592B (nl)
IE (1) IE57809B1 (nl)
IL (1) IL74165A (nl)
IT (1) IT1182150B (nl)
LU (2) LU85743A1 (nl)
NL (2) NL190373C (nl)
NO (2) NO164025C (nl)
NZ (1) NZ210940A (nl)
PH (1) PH22672A (nl)
PT (1) PT79890B (nl)
SE (1) SE460359B (nl)
SG (1) SG7089G (nl)
SK (1) SK404391A3 (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
DE201165T1 (de) * 1985-03-14 1989-04-20 Beecham Group P.L.C., Brentford, Gb Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
AT396870B (de) * 1986-08-07 1993-12-27 Sandoz Ag Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
JP2765845B2 (ja) * 1986-11-21 1998-06-18 グラクソ、グループ、リミテッド 中止症候群の予防の治療薬
US5202343A (en) * 1986-11-28 1993-04-13 Glaxo Group Limited Tricyclic ketones useful as HT3 -receptor antagonists
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
ES2052585T3 (es) * 1986-12-17 1994-07-16 Glaxo Group Ltd Uso de derivados cetonicos en el tratamiento de desordenes cognitivos.
US4918080A (en) * 1987-04-14 1990-04-17 Glaxo Group Limited Imidazollyl containing ketone derivatives
EP0295836B1 (en) * 1987-06-16 1992-09-02 Btg International Limited Use of dioxopiperidine derivatives for the manufacture of topical medicaments as analgesics
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
JPH01258673A (ja) * 1987-10-22 1989-10-16 Glaxo Group Ltd ケトン誘導体
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
US5173493A (en) * 1988-09-27 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Pyridoindole derivatives and processes for preparation thereof
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
US5290785A (en) * 1988-09-27 1994-03-01 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for ischemic diseases
FR2639944B1 (fr) * 1988-12-06 1991-01-18 Adir Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
CA2012092A1 (en) * 1989-03-13 1990-09-13 Tadao Okegawa 5-ht3 receptor antagonist
DK0422154T3 (da) * 1989-04-21 1994-03-07 Sandoz Ag Terapeutisk anvendelse af 5-HT3-receptorantagonister
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
GB8917557D0 (en) * 1989-08-01 1989-09-13 Glaxo Group Ltd Medicaments
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
EP1022025A3 (en) * 1991-06-26 2002-06-05 Sepracor, Inc. Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
CN1118990A (zh) * 1993-03-08 1996-03-20 藤泽药品工业株式会社 治疗或预防脑血管疾病药物
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB2327348A (en) * 1994-06-28 1999-01-27 Kenneth Francis Prendergast Pharmaceutical use of ondansetron
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US7098345B2 (en) 2002-04-29 2006-08-29 TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
ES2238001B1 (es) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
US7288660B2 (en) 2004-05-07 2007-10-30 Taro Pharmaceutical Industries Limited Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
WO2007004041A2 (en) * 2005-07-05 2007-01-11 Orchid Research Laboratories Limited New compounds and their pharmaceutical use
DK2432467T3 (en) 2009-05-20 2018-04-16 Inst Nat Sante Rech Med SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS FOR USE IN TREATMENT OF VESTIBULAR DAMAGE LESSONS
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
CN115611864A (zh) * 2022-11-01 2023-01-17 常州兰陵制药有限公司 一种昂丹司琼类化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740404A (en) * 1969-05-09 1973-06-19 American Cyanamid Co Piperidinomethylenedihydrocarbazolones
US3634420A (en) * 1969-05-09 1972-01-11 American Cyanamid Co 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
NO164025C (no) 1990-08-22
FI84349B (fi) 1991-08-15
CH664152A5 (fr) 1988-02-15
DE19375046I2 (de) 2002-10-10
SK277923B6 (en) 1995-08-09
DK35785D0 (da) 1985-01-25
SE8500368D0 (sv) 1985-01-25
NL190373B (nl) 1993-09-01
SE460359B (sv) 1989-10-02
NL940009I1 (nl) 1994-07-18
AU3809785A (en) 1985-08-01
GB2153821A (en) 1985-08-29
LU85743A1 (fr) 1986-08-04
IE850187L (en) 1985-07-25
CZ404391A3 (en) 1993-04-14
ES548430A0 (es) 1987-10-01
CY1479A (en) 1989-07-21
GR850219B (nl) 1985-05-23
NL8500202A (nl) 1985-08-16
BE901576A (fr) 1985-07-25
FR2561244A1 (fr) 1985-09-20
ES8609309A1 (es) 1986-07-16
IE57809B1 (en) 1993-04-21
FI850323L (fi) 1985-07-26
NO850300L (no) 1985-07-26
PT79890B (en) 1987-02-03
NL940009I2 (nl) 1999-05-03
IT1182150B (it) 1987-09-30
HUT37784A (en) 1986-02-28
GB2153821B (en) 1988-01-20
AT392276B (de) 1991-02-25
ES556101A0 (es) 1987-12-16
AU579132B2 (en) 1988-11-17
ATA20485A (de) 1990-08-15
DK169521B1 (da) 1994-11-21
NO1994022I1 (no) 1994-11-09
ES539852A0 (es) 1986-07-16
FI84349C (fi) 1991-11-25
HK33189A (en) 1989-04-28
LU88268I2 (nl) 1994-02-03
ES8801247A1 (es) 1987-12-16
IL74165A (en) 1988-11-15
NO164025B (no) 1990-05-14
ES8708224A1 (es) 1987-10-01
FI850323A0 (fi) 1985-01-25
SG7089G (en) 1989-06-09
PT79890A (en) 1985-02-01
GB8501889D0 (en) 1985-02-27
HU193592B (en) 1987-11-30
NZ210940A (en) 1989-08-29
SE8500368L (sv) 1985-07-26
IT8547600A0 (it) 1985-01-25
DE3502508C2 (nl) 1990-05-03
KR920003064B1 (ko) 1992-04-13
SK404391A3 (en) 1995-08-09
FR2561244B1 (fr) 1988-03-04
CA1252793A (en) 1989-04-18
DK35785A (da) 1985-07-26
KR850005439A (ko) 1985-08-26
PH22672A (en) 1988-11-14
DE3502508A1 (de) 1985-08-14

Similar Documents

Publication Publication Date Title
NL190373C (nl) Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat.
FI862644A0 (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
MX9203043A (es) Derivados de piridina.
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
NO860226L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1,4-dihydro-4-oksonaftyridin-derivater.
DE3688651D1 (de) Undurchlaessige, unter waerme klebende sperrschicht.
NL300014I2 (nl) Chinolinederivaten en bereidingsprocessen hiervoor.
DE3580304D1 (de) Arzneimittel.
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
FI854573A0 (fi) Farmaceutiska kapslar med foerdroejd frigoering.
FI863037A (fi) Foerfarande och apparat foer faestande, flyttande och staellande av skivor utav flexibelt plastmaterial.
ES2017932B3 (es) Compuestos azaciclicos, procedimientos de su preparacion y su uso como farmacos.
DE3683664D1 (de) Pharmazeutisches tablettierverfahren.
EG19424A (en) Flavolignan derivatives, process for their preparation.
FI852658L (fi) Farmaceutiska aemnen.
EP0226642A4 (en) BENZOYL UREA COMBATINGS, THEIR PRODUCTION METHOD AND PEST CONTROL.
DK131586D0 (da) Transdermalt, antiallergisk, farmaceutisk praeparat
NO875495L (no) 1-acyl-2,3-dihydro-4(1h)-kinolinon-4-oksimderivater.
FI853369A0 (fi) Ny -glukosidasinhibitor, foerfarande foer framstaellning av denna, anvaendning av denna och farmaceutiska preparat.
FI855131A (fi) 8-acylaminoergoliner, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
FI850803A0 (fi) Aminodiarylsulfoxiderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska och pesticida foereningar.
DK160827C (da) Pteridinderivater, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat
FI883442A (fi) Strumpartad naetanordning, saett foer framstaellning av anordningen och apparat foer utfoerande av saettet.
IL97150A0 (en) 1-acyl-2,3-dihydro-4(1h)-quinoline-oxime derivatives
FI850802A0 (fi) Nitraminodiaryl-sulfoxi-derivat, foerfarande foer deras framstaellning och en dessa innehaollande farmaceutisk och pesticidal foerening.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NL CHEMICALS, INC.

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BT A notification was added to the application dossier and made available to the public
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: KRONOS, INC. TE HIGHTSTOWN

BA A request for search or an international-type search has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: RHEOX INTERNATIONAL, INC.

BB A search report has been drawn up
BC A request for examination has been filed
AC1 Application for a supplementary protection certificate

Free format text: 940009, 940531

BV The patent application has lapsed
KC1 Grant of a supplementary protection certificate

Free format text: 940009, 20050125, EXPIRES: 20050222

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20050125